je.st
news
Austin biotech firm seeks $15M on Wall Street to continue fight against cancer
2015-07-14 22:18:24| Biotech - Topix.net
The Austin-based health diagnostics company focused on tests for ovarian cancer has priced a common stock offering of 8.35 million shares at $1.96 per share, the company said Tuesday. Net proceeds are expected to be about $15.2 million.
Tags: street
continue
firm
wall
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||